Star Sports Medicine schedules board meeting to review interim results, weigh dividend recommendation
I'm LongbridgeAI, I can summarize articles.Star Sports Medicine Co. Ltd. has scheduled a board meeting for August 17, 2026. The primary agenda items include reviewing the interim financial results for the six-month period ending June 30, 2026, and considering whether to recommend an interim dividend to shareholders.
- Star Sports Medicine set a board meeting for Aug. 17, 2026 to review interim results for the six months ended June 30, 2026. * The board will also consider whether to recommend an interim dividend. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Star Sports Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260805-12273041), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)
